Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35

Stock OSE IMMUNO (FR0012127173)

Sector : Pharmaceuticals & Biotechnology – Indices : CAC ALL-TRADABLE, CAC ALL SHARES

Price 3,02 €
Daily change -1,63 %
1 week -7,30 %
1 month 0,00 %
1 year -47,09 %

Last update : 24/04/2026 at 17:35:13 – Source: Euronext

Assurance vie

Market summary

As of 24/04/2026, stock OSE IMMUNO trades at 3,02 € , with a change of -1,63 % , and a market cap of 68 M€.

Open0,00 €
Previous close3,07 €
Volume77 493
Market cap68 M€
P/EN/A
Dividend / shareN/A
Float turnover0,00 %
MarketEuronext PARIS
Eligible PEA, SRD

Price and moving averages

Technical analysis OSE IMMUNO

50-day moving average3,66 €-17.38 % (below) Pivot3,05 €
Support level3,02 €-0.13 % Resistance level3,81 €+25.99 %
1-month volatility13,83 % Annualised volatility47,92 %
RSI (14d)37 Neutral Stochastic signal (14d)Neutre
ATR (14d)0,18 Low volatility CMF (21d)-0,06 Weak selling pressure
Bollinger bands (20d) Neutral OBV (21d) Neutral (OBV stable)

Analyst consensus and recommendations

Insufficient data.

Sample rating :
DateAnalyst / BrokerRatingTarget
08/01 Invest Securities achat 10,60 €

Stock history and statistics

IPO dateMar 25, 2015
52-week high5,55 €52-week low2,87 €
All-time high15,80 €All-time low2,70 €
1-year volatility47,92 %Beta0,00

Financial calendar — OSE IMMUNO

📅
April 29, 2026 Annual results 2025
📅
April 30, 2026 Position de trésorerie du Q1 2026
📅
June 24, 2026 Annual General Meeting
📅
September 28, 2026 RESULTATS SEMESTRIELS 2026
📅
October 27, 2026 Position de trésorerie du Q3 2026
📅
January 26, 2027 Position de trésorerie du Q4 2026

Recent news — OSE IMMUNO

OSE Immunotherapeutics announces the selection of its Phase 2 TEDOVA clinical trial results for an oral presentation at the 2026 American Society of C…

OSE Immunotherapeutics announces the appointment of Thomas Gidoin as Deputy CEO and Aurore Morello as Chief Scientific Officer. These changes in its l…

OSE Immunotherapeutics announces the presentation of a new FPR2 agonist monoclonal antibody, described as first-in-class, at the 2026 American Associa…

OSE Immunotherapeutics announces its participation in two investor conferences scheduled for spring 2026. The management will present the company and …

OSE Immunotherapeutics announces the permanent appointment of Marc Le Bozec as CEO, effective immediately. Mr. Le Bozec has been serving in this role …

OSE Immunotherapeutics announces the receipt of a second positive opinion from the Independent Data Monitoring Committee (IDMC) for its pivotal Phase …

Analyses on OSE IMMUNO stock

No analysis has been published on this stock yet.

Frequently asked questions about OSE IMMUNO stock

What does the recent price action of OSE IMMUNO stock show?

OSE IMMUNO stock is currently trading around 3,02 €, down 1,63% and down 0,07% over one week.

Is OSE IMMUNO stock in a support or resistance zone?

Technical levels help place the stock. Support: 3,02 €. Resistance: 3,81 €.

How should the current volatility of OSE IMMUNO stock be interpreted?

Volatility is around 47,92%.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA
BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit